How to Switch Antidepressants: What to Expect During the Transition
Author:
Blossom Editorial
Switching antidepressants is a common part of treatment strategy. In a study of adults with major depression, only about 37% reached remission after the first treatment step with the antidepressant citalopram. This illustrates why some people need to try more than one treatment, rather than indicating that treatment has failed.
There are different ways to move from one antidepressant to another. Providers choose among several switching approaches based on which two medications are involved, how long you have been taking the first one, and how likely you are to have withdrawal symptoms in between.
Key Takeaways
Switching is a well-established option, not a failure: Large trials of depression treatment have found that a substantial share of people need a second medication step. Thus, switching after an inadequate response or troublesome side effects is a common treatment option.
There are several switching methods, and the choice depends on several factors: Options range from a direct switch to a gradual cross-taper to a full washout period, each with different trade-offs between speed and safety. The appropriate method for you depends on the specific medications, doses, treatment duration, and your risk of withdrawal or drug interactions.
Switching should always be prescriber-directed: Overlapping certain antidepressants raises the risk of serotonin toxicity, and stopping one abruptly can cause withdrawal symptoms, so this is not a change to make on your own. Moreover, only a provider can recommend a suitable second treatment option based on your medical history, current medications, and coexisting conditions.
Why People Switch Antidepressants
Most switches happen for one or more of a handful of reasons:
No response: Symptoms have not meaningfully improved after an adequate trial at a therapeutic dose. In this situation, your provider may switch to another antidepressant, either within the same class or to one with a different mechanism of action, depending on your response, side effects, and treatment history.
Partial response: Some improvement, but not enough to feel well or function normally. If a dose increase is not recommended or doesn’t produce much improvement, a different treatment may be considered.
Side effects: Many antidepressant side effects generally get better over the first few weeks. However, some side effects can persist for some people. Sexual side effects, weight change, sedation, or emotional blunting that has not settled with time are some of the side effects that can prompt a medication switch.
A change in circumstances: Pregnancy planning, a new medical diagnosis, or a new medication that interacts. These situations may require a reevaluation of your treatment.
Cost or access: A medication that is no longer covered or affordable.
A revised diagnosis: New information that points toward a different treatment approach.
Before Switching: Confirming It Is the Right Move
A good prescriber will check a few things before changing medications, because a switch that was not needed costs weeks.
The main question is whether the current medication actually had a fair trial: taken consistently, at a therapeutic dose, for long enough.
Most antidepressants need 4 to 8 weeks at an adequate dose before their full effect is clear, although some guidelines recommend reviewing response after two weeks of treatment, with benefit becoming apparent within about 4 weeks.
On the other hand, some people may continue to improve beyond 6-8 weeks. The provider will determine what an adequate duration in your case is.
If doses were frequently missed or the dose was never increased past the starting level, your provider may consider addressing adherence or adjusting the dose before deciding whether a switch is needed. Some of the signs your antidepressant dose is too low look a lot like a medication that is not working at all.
Your provider will also want to rule out other explanations, including an untreated co-occurring condition or a diagnosis that needs revisiting.
The Main Ways Antidepressants Are Switched
Once a switch is decided on, your prescriber will choose a method. Which one they use depends on the pharmacology of both medications, your dose, and your risk of discontinuation symptoms.
Direct Switch
The first medication is stopped, and the new one started the next day. Its advantage is speed and no gap in treatment. This is generally reserved for medications with similar pharmacology, such as moving between certain SSRIs, but whether it is safe depends on the specific drugs, doses, half-lives, interaction risks, and likelihood of discontinuation symptoms.
Cross-Taper
The dose of the first medication is gradually reduced while the new one is gradually increased, so the two overlap for a period. Tapering is generally recommended, as stopping antidepressants cold-turkey can cause severe discontinuation symptoms. For example, a prescriber may gradually reduce an SSRI such as sertraline (Zoloft) while introducing mirtazapine (Remeron) at a low dose, with both medications briefly overlapping.
While a cross-taper can help maintain antidepressant coverage and reduce the risk of discontinuation symptoms, overlapping medications also increases the potential for drug interactions, so it is not appropriate for every combination.
Taper Then Switch
The first medication is tapered down and stopped, then the new one is started shortly afterward without a long gap. This suits situations where overlap carries interaction risk but a lengthy washout is not required, likely because the medication clears the system fairly quickly once stopped.
For example, when switching from the SSRI fluvoxamine (Luvox) to the tricyclic antidepressant clomipramine (Anafranil), the SSRI is gradually reduced and stopped, then low-dose clomipramine can be started the following day. Overlap could be dangerous as fluvoxamine is a potent inhibitor of a liver enzyme, which breaks down clomipramine. Depending on the clinical situation, a prescriber may also include a washout period after stopping fluvoxamine.
Taper With a Washout Period
A more cautious approach: the first medication is tapered off, followed by a defined drug-free interval, called a washout period, before the new one begins. Conservative switching strategies minimize interaction risk but take longer and leave a period without treatment, which carries its own risk of symptoms returning.
The length of the washout depends on the medications involved and their half-lives. In practice, this is used mainly where the combination would be unsafe.
For example, when moving from the SSRI fluoxetine (Prozac) to another SSRI, a direct switch is not recommended due to fluoxetine’s long half-life. Some guidelines recommend gradually reducing the dose to 20 mg per day, then stopping the medication and waiting for 4-7 days to allow the medication and its metabolites to clear the system. Treatment with a low-dose SSRI can then be initiated. However, fluoxetine can still cause medication interactions 5-6 weeks after stopping.
Note: The switching examples provided are illustrative and do not comprise standard protocols. Antidepressant switches are individualized, and your prescriber may recommend a different approach based on the medications involved, your dose, treatment history, and other health factors. Do not stop or change an antidepressant without medical guidance.
Two Situations Handled Differently
Certain medications change the calculation entirely, which is one reason switching must be administered by a prescriber on a case-by-case basis.
Monoamine oxidase inhibitors or MAOIs, an older class of antidepressants, require a washout before and after because combining them with most other antidepressants can cause serious interactions, including serotonin toxicity. When switching from an SSRI or SNRI antidepressant to an MAOI, providers typically include a 14-day washout period. In the case of fluoxetine, that could be 5-6 weeks.
As mentioned earlier, fluoxetine is another SSRI that must be switched with caution due to an unusually long half-life. Providers typically build in longer intervals when moving off it.
What to Expect During the Switch
The transition period is usually the least comfortable part, and knowing what is normal helps:
Temporary antidepressant discontinuation symptoms: Dizziness, nausea, headache, irritability, vivid dreams, or electric-shock sensations can occur as the first medication comes down, particularly with shorter half-life drugs. Not everyone experiences these symptoms, and their severity varies from person to person.
Start-up side effects from the new medication: Nausea, sleep changes, and jitteriness are common in the first week or two after starting a new antidepressant. These may improve within the first few weeks, but tell your prescriber if they are severe, persistent, or worsening.
Close monitoring: Your prescriber may arrange more frequent follow-up during the switch, depending on the medications involved, your symptoms, and your individual risks..
A written plan: A good switch comes with instructions on what to take when, and what to do if specific symptoms appear.
Distinguishing discontinuation symptoms from the old medication, side effects from the new one, and a genuine return of symptoms of the underlying condition is difficult from the inside, which is why reporting what you notice matters more than interpreting it yourself.
How Long Does Switching Antidepressants Take?
The transition can take anywhere from days to several weeks or longer, depending on the medications involved, how slowly the first medication needs to be tapered, and whether a washout is required.
After the switch, your prescriber will usually allow enough time to assess the new medication's effects, often several weeks and sometimes longer when symptoms are improving and the medication is tolerated.
Realistically, a full switch and evaluation cycle could take two to three months or even longer, though the overall timeline can vary considerably, depending on the medication and individual factors. If a second medication also falls short, that does mean nothing will work, though it does shift the conversation toward augmentation strategies or a workup for treatment-resistant depression. Once you land on something effective, the question becomes how long to take antidepressants to protect the improvement and maintain it over the long term.
Risks Worth Understanding
The two risks that shape how switches are designed are serotonin toxicity from overlapping serotonergic medications (medications that impact serotonin, such as SSRIs and SNRIs), and discontinuation symptoms or relapse from stopping too quickly. A carefully planned switch can reduce these risks, but both discontinuation symptoms and serotonin toxicity can sometimes be serious and require prompt medical attention.
Switching antidepressants differs from stopping treatment altogether. When no replacement medication is being started, the original antidepressant is usually tapered according to a separate plan, which may take several weeks or longer.
When to Seek Medical Attention
Contact your prescriber promptly, or seek urgent care, if during a switch you experience:
Thoughts of harming yourself or someone else, especially if you have intent, a plan, or feel unable to keep yourself or another person safe
Agitation, confusion, high fever, muscle rigidity, tremor, heavy sweating, or a racing heartbeat after combining or changing serotonergic medications can be a sign of serotonin toxicity and requires urgent medical assessment
A sharp or significant worsening of mood or anxiety, especially if you feel unsafe or unable to function
Unusually elevated or irritable mood, markedly reduced need for sleep, racing thoughts, or unusually increased energy or impulsivity
Signs of a severe allergic reaction, including rash, swelling, or difficulty breathing, which could be a medical emergency
In an emergency, call 911 or go to the nearest emergency room. The 988 Suicide and Crisis Lifeline is available by call or text at any time.
How Blossom Health Can Help
Switching antidepressants goes better with frequent prescriber contact, which is why care often breaks down when appointments are months apart. Blossom Health is a psychiatry-first telehealth practice where every provider is a board-certified, licensed psychiatric provider who can evaluate, diagnose, adjust, and prescribe.
Follow-ups can be scheduled to match the pace of a transition. With 24/7 email and text support from a care team, any questions that come up about symptoms or side effects during the changeover can be addressed right away. Care is covered by in-network insurance, and you can check your coverage when you get started.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Never start, stop, or change a prescription medication without guidance from your prescriber. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition or medication. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Sources
Keks, N., Hope, J., & Keogh, S. (2016). Switching and stopping antidepressants. Australian prescriber, 39(3), 76–83. https://pubmed.ncbi.nlm.nih.gov/27346915/
Mills, N. T., Sampson, E., Fourrier, C., & Baune, B. T. (2021). Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial. The international journal of neuropsychopharmacology, 24(4), 314–321. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059490/
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. The American journal of psychiatry, 163(11), 1905–1917. https://pubmed.ncbi.nlm.nih.gov/17074942/
National Health Service, Specialist Pharmacy Service. (2024, April 11). SSRIs to other antidepressants: Switching in adults. https://sps.nhs.uk/articles/ssris-to-other-antidepressants-switching-in-adults/
American Psychiatric Association. (2010). Practice guideline for the treatment of patients with major depressive disorder (3rd ed.). https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf
Zhu, M., Hong, R. H., Yang, T., et al. (2021). The Efficacy of Measurement-Based Care for Depressive Disorders: Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of clinical psychiatry, 82(5), 21r14034. https://pubmed.ncbi.nlm.nih.gov/34587377/
Henssler, J., Schmidt, Y., Schmidt, U., Schwarzer, G., Bschor, T., & Baethge, C. (2024). Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The lancet. Psychiatry, 11(7), 526–535. https://pubmed.ncbi.nlm.nih.gov/38851198/
National Institute of Mental Health. (2023, December). Mental health medications. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/mental-health-medications
Chand SP, Arif H. Depression. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430847/
Kommu S, Carter C, Whitfield P. Adverse Drug Reactions. [Updated 2024 Jan 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK599521/
U.S. Food and Drug Administration. (n.d.). MedWatch: FDA safety information and adverse event reporting program. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
